M. Grigoryan

Should We Monitor Glucose and Biomarkers in Diabetics over Heart Surgery?

E. Golukhova, N. Bulaeva, Yaroslava V. Pugovkina, 2021, Journal of clinical medicine.

[High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention].

E. Golukhova, N. Bulaeva, M. Grigoryan, 2018, Kardiologiia.

Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy

V. Serebruany, E. Golukhova, N. Bulaeva, 2018, Cardiology.

High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention.

E. Golukhova, N. Bulaeva, M. Grigoryan, 2018, Kardiologiia.

Stroke etiology and collaterals: atheroembolic strokes have greater collateral recruitment than cardioembolic strokes

M. Bouslama, D. Haussen, J. Grossberg, 2017, European journal of neurology.

Noninvasive Predictors of Malignant Arrhythmias

V. Serebruany, L. Bockeria, E. Golukhova, 2016, Cardiology.